Privia Health Group, Inc. announced the election of Opella Ernest, M.D., to its Board of Directors as a Class III director, effective September 1, 2026. Dr. Ernest will also serve on the Compliance Committee and is considered independent under Nasdaq rules. Her compensation includes an annual cash retainer and a pro-rated equity grant of restricted stock units valued at $200,000 under the Company’s 2021 Omnibus Incentive Plan. Dr. Ernest brings over 20 years of healthcare executive experience, currently serving as President of HCSC Markets at Health Care Service Corporation. Privia Health Group operates in the healthcare industry, providing physician enablement services and building scaled provider networks across the United States.

Privia Health Group, Inc. reported financial results for the second quarter ended June 30, 2026, announcing a net income of $9.0 million, a 236.7% increase from the prior year period. Total revenue reached $632.6 million, up 21.4%, while Adjusted EBITDA grew 29.1% to $37.4 million. The company raised its full-year 2026 guidance across all key financial metrics, including attributed lives and adjusted EBITDA. Privia Health Group operates in the healthcare industry as a physician enablement company that builds scaled provider networks and provides technology solutions.

Shawn Morris resigned from the Board of Directors and the Compliance Committee of Privia Health Group, Inc. effective July 6, 2026. The resignation was not due to any disagreement with the company's operations, policies, or practices. Privia Health Group, Inc. operates in the healthcare services industry providing physician-led healthcare solutions.